Nuvation Bio
NUVB · NYSE
$4.77+$0.29 (+6.47%)TodayMarket closed ·
Prev close $4.48
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 7.6% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.1888 | -$0.15 | +20.6% |
| Q1 FY26 | $0.0092 | $0.01 | +8.7% |
| Q4 FY25 | -$0.0911 | -$0.11 | −20.7% |
| Q3 FY25 | -$0.172 | -$0.16 | +7.0% |
| Q2 FY25 | -$0.1715 | -$0.17 | +0.9% |
| Q1 FY25 | -$0.1615 | -$0.16 | +0.9% |
| Q4 FY24 | -$0.1408 | -$0.15 | −6.5% |
| Q3 FY24 | -$0.1326 | -$0.15 | −13.1% |
Earnings calls
- 12th Annual Cantor Fitzgerald Global Healthcare Conference
- Citigroup’s Biopharma Back to School Summit 2026
- NUVB - Earnings call Q2 2026
- Jefferies Global Healthcare Conference 2026
- TD Cowen’s 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA
- RBC Capital Markets Global Healthcare Conference 2026
- H.C. Wainwright 4th Annual BioConnect Investor Conference
- Bank of America Global Healthcare Conference 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.